☆ 4.7 Article

LRRK2 exonic variants and risk of multiple system atrophy

NEUROLOGY (2014)

获取全文
添加到收藏夹

期刊

NEUROLOGY
卷 83, 期 24, 页码 2256-2261

出版社

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1212/WNL.0000000000001078

关键词

-

类别

Clinical Neurology

资金

  1. NIH/National Institute of Neurological Disorders and Stroke [P50 NS072187]
  2. National Institute of Neurological Disorders and Stroke [R01 NS078086]
  3. Michael J. Fox Foundation for Parkinson's Research
  4. Canada Excellence Research Chairs program
  5. Dr. Donald Rix BC Leadership Chair
  6. Cundill Foundation
  7. Reta Lila Weston Institute for Neurological Studies
  8. Multiple System Atrophy Trust
  9. Department of Health's NIHR Biomedical Research Centres funding scheme
  10. Medical Research Council [G1100695, G0802760, G108/638, MR/J004758/1, G1001253] Funding Source: researchfish
  11. Parkinson's UK [G-0909] Funding Source: researchfish
  12. MRC [G1001253, MR/J004758/1, G0802760, G108/638, G1100695] Funding Source: UKRI

向作者/读者索取更多资源

Protocol

社区支持

Reagent

社区支持

Objective:The aim of this study was to evaluate the association between common exonic variants in the leucine-rich repeat kinase 2 (LRRK2) gene and risk of multiple system atrophy (MSA).Methods:One series from the United States (92 patients with pathologically confirmed MSA, 416 controls) and a second series from the United Kingdom (85 patients with pathologically confirmed MSA, 352 controls) were included in this case-control study. We supplemented these data with those of 53 patients from the United States with clinically probable or possible MSA. Seventeen common LRRK2 exonic variants were genotyped and assessed for association with MSA.Results:In the combined series of 177 patients with pathologically confirmed MSA and 768 controls, there was a significant association between LRRK2 p.M2397T and MSA (odds ratio [OR] = 0.60, p = 0.002). This protective effect was observed more strongly in the US series (OR = 0.46, p = 0.0008) than the UK series (OR = 0.82, p = 0.41). We observed other noteworthy associations with MSA for p.G1624G (OR = 0.63, p = 0.006) and p.N2081D (OR = 0.15, p = 0.010). The p.G1624G-M2397T haplotype was significantly associated with MSA in the US series (p < 0.0001) and combined series (p = 0.003) but not the UK series (p = 0.67). Results were consistent when additionally including the US patients with clinical MSA, where the strongest single-variant association was again observed for p.M2397T (OR = 0.59, p = 0.0005).Conclusions:These findings provide evidence that LRRK2 exonic variants may contribute to susceptibility to MSA. Validation in other series and meta-analytic studies will be important.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Clinical Neurology

Phosphorylated tau sites that are elevated in Alzheimer's disease fluid biomarkers are visualized in early neurofibrillary tangle maturity levels in the post mortem brain

Christina M. Moloney, Sydney A. Labuzan, Julia E. Crook, Habeeba Siddiqui, Monica Castanedes-Casey, Christian Lachner, Ronald C. Petersen, Ranjan Duara, Neill R. Graff-Radford, Dennis W. Dickson, Michelle M. Mielke, Melissa E. Murray

Summary: This study aims to characterize the recognition of phosphorylated tau sites in early neurofibrillary tangle maturity levels, which may explain why these fluid biomarkers can be observed before symptom onset.

ALZHEIMERS & DEMENTIA (2023)

添加到收藏夹
Article Chemistry, Organic

Comparison of [18F]F-CNBI and [18F]F-CNPIFE as Positron Emission Tomography Probes for Noninvasive Imaging of Glycogen Synthase Kinase-3 in Normal Mice

Heather M. Stein, Surendra R. Gundam, Aditya Bansal, Nicholas R. Nelson, Geoffry L. Curran, Timothy R. DeGrado, Mark A. Frye, John D. Port, Val J. Lowe, Melissa E. Murray, Mukesh K. Pandey

Summary: This study synthesized two PET probes and evaluated their permeability through the blood-brain barrier and affinity towards GSK-3 alpha/beta. The results showed that [F-18]F-CNPIFE had higher brain uptake compared to [F-18]F-CNBI, making it a promising PET probe for imaging GSK-3 alpha/beta.

EUROPEAN JOURNAL OF ORGANIC CHEMISTRY (2023)

添加到收藏夹
Article Clinical Neurology

A Genome-Wide Association Study of Outcome After Aneurysmal Subarachnoid Haemorrhage: Discovery Analysis

Ben Gaastra, Sheila Alexander, Mark K. Bakker, Hemant Bhagat, Philippe Bijlenga, Spiros L. Blackburn, Malie K. Collins, Sylvain Dore, Christoph J. Griessenauer, Philipp Hendrix, Eun Pyo Hong, Isabel C. Hostettler, Henry Houlden, Koji IIhara, Jin Pyeong Jeon, Bong Jun Kim, Jiang Li, Sandrine Morel, Paul Nyquist, Dianxu Ren, Ynte M. Ruigrok, David Werring, Will Tapper, Ian Galea, Diederik Bulters

Summary: This study identified 157 genetic variants associated with outcomes after aneurysmal subarachnoid haemorrhage (aSAH) through a genome-wide association study, with one variant in the SPNS2 gene achieving genome-wide significance. Validation of these findings will provide significant insights into the pathophysiology of outcomes after aSAH and may have implications for treatment.

TRANSLATIONAL STROKE RESEARCH (2023)

添加到收藏夹
Article Clinical Neurology

Functional genomics provide key insights to improve the diagnostic yield of hereditary ataxia

Zhongbo Chen, Arianna Tucci, Valentina Cipriani, Emil K. Gustavsson, Kristina Ibanez, Regina H. Reynolds, David Zhang, Letizia Vestito, Alejandro Cisterna Garcia, Siddharth Sethi, Jonathan W. Brenton, Sonia Garcia-Ruiz, Aine Fairbrother-Browne, Ana-Luisa Gil-Martinez, Nick Wood, John A. Hardy, Damian Smedley, Henry Houlden, Juan Botia, Mina Ryten

Summary: Using a systems biology approach, Chen et al. found that genes associated with adult- and child-onset ataxia share common characteristics, including a high density of short tandem repeats. Removing the age-of-onset partition and screening for repeat expansions could improve the diagnosis of hereditary ataxia.

BRAIN (2023)

添加到收藏夹
Article Clinical Neurology

HLA-DRB1*1501 influences long-term disability progression and tissue damage on MRI in relapse-onset multiple sclerosis

Wallace J. Brownlee, Carmen Tur, Andreea Manole, Arman Eshaghi, Ferran Prados, Katherine A. Miszkiel, Claudia A. M. Gandini Wheeler-Kingshott, Henry Houlden, Olga Ciccarelli

Summary: This study found that HLA-DRB1*1501 is associated with the severity of multiple sclerosis (MS), as indicated by long-term disability worsening and greater extent of inflammatory disease activity and tissue loss. HLA-DRB1*1501 may provide useful information for prognosis and treatment decisions in early relapse-onset MS.

MULTIPLE SCLEROSIS JOURNAL (2023)

添加到收藏夹
Article Genetics & Heredity

Genetic Insights from Consanguineous Cardiomyopathy Families

Constance Maurer, Olga Boleti, Paria Najarzadeh Torbati, Farzaneh Norouzi, Anna Nicole Rebekah Fowler, Shima Minaee, Khalid Hama Salih, Mehdi Taherpour, Hassan Birjandi, Behzad Alizadeh, Aso Faeq Salih, Moniba Bijari, Henry Houlden, Alan Michael Pittman, Reza Maroofian, Yahya H. Almashham, Ehsan Ghayoor Karimiani, Juan Pablo Kaski, Eissa Ali Faqeih, Farveh Vakilian, Yalda Jamshidi

Summary: Inherited cardiomyopathies are a prevalent cause of heart failure and sudden cardiac death. Whole exome sequencing and autozygosity mapping in Middle Eastern families with hypertrophic and dilated cardiomyopathy identified variants in TNNI3K, DSP, RBCK1, NRAP, and KLHL24 genes associated with different phenotypes. This expands the mutational spectrum and suggests novel modes of inheritance for recessive cardiomyopathies.

GENES (2023)

添加到收藏夹
Article Education, Special

Mitochondrial DNA involvement in patients with autism spectrum disorders and intellectual disability

Carmela Scuderi, Sandro Santa Paola, Mariangela Lo Giudice, Francesco Domenico Di Blasi, Stefania Giusto, Giuseppa Di Vita, Rosa Pettinato, Girolamo Aurelio Vitello, Corrado Romano, Serafino Buono, Vincenzo Salpietro, Henry Houlden, Eugenia Borgione

Summary: This study aimed to identify mitochondrial dysfunction due to mtDNA variants in 19 selected subjects with ASD and clinical features of mitochondrial disease. The results showed that 79% of the patients had myogenic or neurogenic changes in the histological examination, 58% had lipid accumulation, mitochondrial proliferation, and COX-deficient fibers. Biochemical investigations revealed impairments involving one or more of the respiratory chain complexes in three patients. Genetic studies found multiple mtDNA deletions in one patient with normal histology and biochemistry, and different mtDNA point mutations in four patients.

RESEARCH IN AUTISM SPECTRUM DISORDERS (2023)

添加到收藏夹
Article Clinical Neurology

Unexpected frequency of the pathogenic AR CAG repeat expansion in the general population

Matteo Zanovello, Kristina Ibanez, Anna-Leigh Brown, Prasanth Sivakumar, Alessandro Bombaci, Liana Santos, Joke J. F. A. van Vugt, Giuseppe Narzisi, Ramita Karra, Sonja W. Scholz, Jinhui Ding, J. Raphael Gibbs, Adriano Chio, Clifton Dalgard, Ben Weisburd, Michael G. Hanna, Linda Greensmith, Hemali Phatnani, Jan H. Veldink, Bryan J. Traynor, James Polke, Henry Houlden, Pietro Fratta, Arianna Tucci

Summary: The researchers established a method to detect AR CAG expansions and found a higher mutation frequency than previously reported, possibly due to underdiagnosis or pleomorphic manifestations. This mutation causes spinal and bulbar muscular atrophy, a male-specific progressive neuromuscular disorder.

BRAIN (2023)

添加到收藏夹
Article Clinical Neurology

Molecular basis of FAAH-OUT-associated human pain insensitivity

Hajar Mikaeili, Abdella M. Habib, Charlix Wai-Lok Yeung, Sonia Santana-Varela, Ana P. Luiz, Kseniia Panteleeva, Sana Zuberi, Alkyoni Athanasiou-Fragkouli, Henry Houlden, John N. Wood, Andrei L. Okorokov, James J. Cox

Summary: Mikaeili et al. have identified the molecular basis of pain insensitivity associated with FAAH-OUT. This discovery provides insights into the regulation of pain and offers potential for new gene therapy approaches. Chronic pain affects millions of people worldwide and requires urgent treatment options.

BRAIN (2023)

添加到收藏夹
Article Clinical Neurology

Progression of atypical parkinsonian syndromes: PROSPECT-M-UK study implications for clinical trials

Duncan Street, Edwin Jabbari, Alyssa Costantini, P. Simon Jones, Negin Holland, Timothy Rittman, Marte T. Jensen, Viorica Chelban, Yen Y. Goh, Tong Guo, Amanda J. Heslegrave, Federico Roncaroli, Johannes C. Klein, Olaf Ansorge, Kieren S. J. Allinson, Zane Jaunmuktane, Tamas Revesz, Thomas T. Warner, Andrew J. Lees, Henrik Zetterberg, Lucy L. Russell, Martina Bocchetta, Jonathan D. Rohrer, David J. Burn, Nicola Pavese, Alexander Gerhard, Christopher Kobylecki, P. Nigel Leigh, Alistair Church, Michele T. M. Hu, Henry Houlden, Huw Morris, James B. Rowe

Summary: The study compares candidate clinical trial end points in progressive supranuclear palsy, multiple system atrophy, corticobasal syndrome and related disorders. Neuroimaging metrics generally require smaller sample sizes than cognitive and functional measures, but the optimal outcome measures differ by disease type.

BRAIN (2023)

添加到收藏夹
Article Clinical Neurology

The clinical and genetic spectrum of autosomal-recessive TOR1A-related disorders

Afshin Saffari, Tracy Lau, Homa Tajsharghi, Ehsan Ghayoor Karimiani, Ariana Kariminejad, Stephanie Efthymiou, Giovanni Zifarelli, Tipu Sultan, Mehran Beiraghi Toosi, Sahar Sedighzadeh, Victoria Mok Siu, Juan Dario Ortigoza-Escobar, Aisha M. AlShamsi, Shahnaz Ibrahim, Nouriya Abbas Al-Sannaa, Walla Al-Hertani, Whalen Sandra, Mark Tarnopolsky, Shahryar Alavi, Chumei Li, Debra-Lynn Day-Salvatore, Maria Jesus Martinez-Gonzalez, Kristin M. Levandoski, Emma Bedoukian, Suneeta Madan-Khetarpal, Michaela J. Idleburg, Minal Juliet Menezes, Aishwarya Siddharth, Konrad Platzer, Henry Oppermann, Martin Smitka, Felicity Collins, Monkol Lek, Mohmmad Shahrooei, Maryam Ghavideldarestani, Isabella Herman, John Rendu, Julien Faure, Janice Baker, Vikas Bhambhani, Laurel Calderwood, Javad Akhondian, Shima Imannezhad, Hanieh Sadat Mirzadeh, Narges Hashemi, Mohammad Doosti, Mojtaba Safi, Najmeh Ahangari, Paria Najarzadeh Torbati, Soheila Abedini, Vincenzo Salpietro, Elif Yilmaz Gulec, Safieh Eshaghian, Mohammadreza Ghazavi, Michael T. Pascher, Marina Vogel, Angela Abicht, Sebastien Moutton, Ange-Line Bruel, Claudine Rieubland, Sabina Gallati, Tim M. Strom, Hanns Lochmueller, Mohammad Hasan Mohammadi, Javeria Raza Alvi, Elaine H. Zackai, Beth A. Keena, Cara M. Skraban, Seth Berger, Erin H. Andrew, Elham Rahimian, Michelle M. Morrow, Ingrid M. Wentzensen, Francisca Millan, Lindsay B. Henderson, Hormos Salimi Dafsari, Heinz Jungbluth, Natalia Gomez-Ospina, Anne McRae, Merlene Peter, Danai Veltra, Nikolaos M. Marinakis, Christalena Sofocleous, Farah Ashrafzadeh, Davut Pehlivan, Johannes R. Lemke, Judith Melki, Audrey Benezit, Peter Bauer, Denisa Weis, James R. Lupski, Jan Senderek, John Christodoulou, Wendy K. Chung, Rose Goodchild, Amaka C. Offiah, Andres Moreno-De-Luca, Mohnish Suri, Darius Ebrahimi-Fakhari, Henry Houlden, Reza Maroofian

Summary: This study systematically assesses the characteristics of 56 individuals with autosomal-recessive TOR1A-related disease, including their clinical, radiological, and molecular features. The study defines the phenotypic spectrum, identifies core clinical symptoms, and highlights predictors for disease severity and survival.

BRAIN (2023)

添加到收藏夹
Article Developmental Biology

Exome sequencing identifies a novel pathogenic variant in RAB3GAP1 causing Warburg Micro syndrome in a Pakistani family

Wahid Ullah, Muhammad Ilyas, Muhammad Tariq, Maria Imdad, Ikram Ullah, Stephanie Efthymiou, Muhammad Faheem, Muhammad Abbas, Muhammad Aamir, Muhammad Nouman, Henry Houlden, S. Y. N. A. P. S. Study Group SYNAPS Study Group

Summary: This study identified the genetic basis of WARBM syndrome in a Pashtun family from Pakistan. MRI analysis showed cerebral atrophy and exome sequencing identified a novel variant in the RAB3GAP1 gene. This rare variant expands the mutation spectrum of Micro syndrome.

INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE (2023)

添加到收藏夹
Review Clinical Neurology

Current advances in the surgical treatment of glossopharyngeal neuralgia

Manuela Aramburu Berckemeyer, Paola Suarez-Meade, Maria Fernanda Villamonte Carcelen, Mariel Dyer Ricci, William P. Cheshire, Daniel M. Trifiletti, Erik H. Middlebrooks, Alfredo Quinones-Hinojosa, Sanjeet S. Grewal

Summary: Glossopharyngeal neuralgia (GPN) is a neurological condition characterized by paroxysmal, stabbing-like pain. Pharmacological treatment is the first line, but some patients require surgical intervention. A systematic review showed that microvascular decompression (MVD) alone achieved immediate pain relief in 85% of patients and long-term relief in 65-90% of patients. Rhizotomy alone provided instant relief in 85-100% of patients, but long-term relief was lower. Stereotactic radiosurgery (SRS) had promising results in pain reduction, but further studies are needed.

NEUROSURGICAL REVIEW (2023)

添加到收藏夹
Review Clinical Neurology

DNAJC12 in Monoamine Metabolism, Neurodevelopment, and Neurodegeneration

Isaac Bul Deng, Jordan Follett, Mengfei Bu, Matthew J. Farrer

Summary: Recent studies have shown that pathogenic variants in DNAJC12 can cause various diseases, including mild hyperphenylalaninemia, infantile dystonia, young-onset parkinsonism, developmental delay and cognitive deficits. DNAJC12 has been included in newborn screening, particularly in Spain, emphasizing the importance of genetic diagnosis and early intervention. However, many practitioners may not be aware of these advances, and molecular testing for DNAJC12 is yet to be conducted for many patients, especially adults. This review provides a summary of genotype-phenotype relationships and treatment approaches for patients with pathogenic variants in DNAJC12, as well as an overview of the protein's structure, known genetic variants, domains, binding partners, and its role in monoamine synthesis, disease etiology, and pathogenesis.

MOVEMENT DISORDERS (2023)

添加到收藏夹
Article Clinical Neurology

Frequency of Comorbid Pathologies and Their Clinical Impact in Multiple System Atrophy

Hiroaki Sekiya, Shunsuke Koga, Aya Murakami, Michael Deture, Owen A. Ross, Ryan J. Uitti, William P. Cheshire, Zbigniew K. Wszolek, Dennis W. Dickson

Summary: Comorbid pathologies are uncommon in multiple system atrophy (MSA), even in advanced age, indicating its uniqueness among neurodegenerative disorders. These comorbid pathologies have minimal clinical impact on MSA.

MOVEMENT DISORDERS (2023)

添加到收藏夹
暂无数据
研讨会 海报 问题 讨论圈 基金 期刊 论文 科研社交 资讯集成 审稿人 关于我们 常见问题 移动App 隐私条款 使用条款
© Peeref 2019-2024. All rights reserved.